アプタマー アフェレシス 核酸医薬の開発|タグシクス・バイオ株式会社

News Release

rss
2020.11.17
News Release Showa Denko Materials and the Drug Development Startup TAGCyx Sign a Commissioned Development Agreement on Regenerative Medicine Technologies
2020.9.18
News Release TAGCyx announces a research collaboration with CAGE Bio Inc. for autoimmune skin diseases.
2020.5.5
News Release TAGCyx raises approximately 200 million JPY
2020.2.19
News Release TAGCyx and GC Pharma has entered into collaborative research and development for conducting various pre-clinical studies of TAGX-0004
2019.12.25
News Release TAGCyx receives milestone payment for collaborative research with HEALIOS K.K.
2019.10.10
News Release TAGCyx enters into a collaborative aptamer glycosylation research agreement with GlyTech, Inc.
2019.10.9
News Release TAGCyx has executed a collaborative antibody-aptamer conjugate research agreement with Chiome Bioscience Inc.
2018.9.28
News Release TAGCyx has executed collaborative research agreement with HEALIOS K.K.
2018.4.29
News Release Completion of 500 million JPY Series B financing
2017.2.1
News Release TAGCyx has executed a research and development collaboration agreement with a European biopharma company in February. The partnership will continue for 2 years which is extendable with mutual agreement and will apply the TAGcyx platform towards the identificatio
2016.8.31
News Release TagCyx announces the completion of 500 million Japanese Yen (US$ 4.9 Million, as of Aug. 31, 2016) private financing, led by The University of Tokyo Edge Capital as a lead investor, and SMBC Venture Capital, Nissay Capital CO., LTD. (Aug 2016)